rinvoq vs xeljanz xr

Rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis are all conditions that can be treated with the drug tofacitinib, which is also marketed under the name Xeljanz. Diarrhea, headaches, and elevated blood pressure are common adverse effects. 

​​Take this medication by mouth once daily, generally with or without meal, as prescribed by your doctor. Completely swallow the pills. The pills should not be broken, divided, or chewed. This might cause the medicine to leak completely all at once, raising the possibility of negative effects.

Cancer, pulmonary embolism, and infections are examples of serious adverse effects. Upper respiratory tract infection, cold-like symptoms, diarrhea, rash, herpes zoster infection (shingles), and headache are among the most frequent side effects of Xeljanz. Additionally, the medication has the potential to result in more serious issues like fatal infections, heart issues, cancer, blood clots, and even death.
 

RINVOQ, on the other hand, is a JAK inhibitor that acts within your cells to disrupt certain signals considered to be the source of inflammation.

RINVOQ, a once-daily medication, has been demonstrated in clinical tests to help manage symptoms in 6 illnesses.

Adults with moderate to severe rheumatoid arthritis (RA) who have tried one or more tumour necrosis factor (TNF) blocker medications but found that they did not work or could not be tolerated might take RINVOQ, a prescription medication.

Adults with active psoriatic arthritis (PsA) who have tried one or more TNF blockers but found that they either did not function as well as expected or were intolerable.